89bio reports first quarter 2021 financial results and provides corporate update

Enliven phase 2b trial in nash expected to be initiated in 2q21 enliven phase 2b trial in nash expected to be initiated in 2q21
ETNB Ratings Summary
ETNB Quant Ranking